Nortriptyline, a treatment for depression that's been around for more than 50 years could slow down the progression of Parkinson's disease, according to a Michigan State University (MSU) study published in the journal Neurobiology of Disease.
In the proof-of-concept study, the antidepressant stopped the growth of abnormal proteins that can build up in the brain and lead to the development of Parkinson's. Keep reading for the full findings.
Nortriptyline has been used to treat nerve pain...
According to the researchers behind the study, nortriptyline has been used to treat depression
and nerve pain
. They say that their study is early proof that the antidepressant could also slow down the progression of Parkinson’s.
is a very frequent condition associated with Parkinson’s, so we became interested in whether an antidepressant could modify how the disease progresses,” said Tim Collier, lead author of the study and a neuroscientist at MSU.
This group of nutrients is not only the answer to boosting your mood... Preventing Alzheimer's and dementia... It's also 8 TIMES MORE EFFECTIVE than an Anti-Depressant!...
Nature’s secret to optimum mental health...
And it’s all thanks to the “Omega 3 Effect”
Protects you from depression and other mood disorders including schizophrenia.
Improves memory and learning. (In fact, studies show kids who take Omega 3 supplements do better at school, score higher in tests and have fewer behavioural issues than those who don’t.)
Fights age-related memory loss and senior moments synonymous with dementia and Alzheimer’s.
And protects against stress-related job burnout.
Study finds a treatment for depression that could slow down the progression of Parkinson’s disease...
To reach their findings, Collier and collaborator, Katrina Paumier, an assistant professor of molecular medicine, began looking at previous data to see if people who used antidepressants experienced any delay in their need to go on a standard Parkinson’s therapy called levodopa. This therapy boosts dopamine, a natural chemical that sends signals to other nerve cells and can drastically decrease in cases of Parkinson’s.
“We found that those on a certain class of antidepressant, called tricyclics, didn’t need the levodopa therapy until much later compared to those who weren’t on that type of antidepressant medication,” reported Collier.
Collier then began testing rats with the antidepressant nortriptyline and found that it was able to reduce the amount of abnormal protein that can accumulate in the brain. This protein can cause the brain’s nerve cells to die and is a hallmark sign of Parkinson’s.
Understanding how these proteins cluster together can help researchers find other possible antidepressants that could potentially treat Parkinson’s. Who would’ve guessed that a treatment for depression
could slow down the progression of Parkinson’s?
Note: 5 of 1 vote